|Title:||Fosinopril tablet formulations|
|Abstract:||Shelf stable tablets containing fosinopril sodium are prepared by employing either sodium stearyl fumarate or hydrogenated vegetable oil as the lubricant. The tablets can contain conventional excipients such as fillers, binders, and disintegrants as well as an optional diuretic.|
|Inventor(s):||Jerzewski; Robert L. (East Millstone, NJ), Wong; Thomas M. (North Brunswick, NJ), Gryziewicz; Lewis J. (North Brunswick, NJ), Jain; Nemichand B. (Monmouth Junction, NJ), Thakur; Ajit B. (East Brunswick, NJ)|
|Assignee:||E. R. Squibb & Sons, Inc. (Princeton, NJ)|
Patent Claim Types:|
see list of patent claims
|Composition; Compound; Dosage form;|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|German Democratic Republic||299154||► subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.